AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19

LONDON — The COVID-19 vaccine developed by the British drug group AstraZeneca and the University of Oxford has achieved a “winning formula” for efficacy, the company’s chief executive said on Sunday.

Problem, Solution, SitRep, or ?: 

Wars, instability pose vaccine challenges in poor nations

Countering Covid-19 -- Field hospitals are increasing being used. Here's a look inside a Rhode Island one

December is the deadliest month in the US since the coronavirus pandemic began -- and projections for January are 'nightmarish,' expert says

How Much Herd Immunity Is Enough?

At what point does a country achieve herd immunity? What portion of the population must acquire resistance to the coronavirus, either through infection or vaccination, in order for the disease to fade away and life to return to normal?

Since the start of the pandemic, the figure that many epidemiologists have offered has been 60 to 70 percent. That range is still cited by the World Health Organization and is often repeated during discussions of the future course of the disease.

Although it is impossible to know with certainty what the limit will be until we reach it and transmission stops, having a good estimate is important: It gives Americans a sense of when we can hope to breathe freely again.

Recently, a figure to whom millions of Americans look for guidance — Dr. Anthony S. Fauci, an adviser to both the Trump administration and the incoming Biden administration — has begun incrementally raising his herd-immunity estimate.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

'The beginning of the end': Europe rolls out vaccines to fight pandemic

How quickly the US lost 1 in 1,000 Americans to Covid-19

(CNN) The United States reached a grim milestone on Saturday: 1 in 1,000 Americans have died from Covid-19 since the nation's first reported infection in late January.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Early Vaccine Doubters Now Show a Willingness to Roll Up Their Sleeves

Ever since the race to develop a coronavirus vaccine began last spring, upbeat announcements were stalked by ominous polls: No matter how encouraging the news, growing numbers of people said they would refuse to get the shot.

The time frame was dangerously accelerated, many people warned. The vaccine was a scam from Big Pharma, others said. A political ploy by the Trump administration, many Democrats charged. The internet pulsed with apocalyptic predictions from longtime vaccine opponents, who decried the new shot as the epitome of every concern they’d ever put forth.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU prepares to launch COVID-19 vaccinations, Hungary started today

A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines

In an ideal world, a pandemic vaccine could be delivered in a single shot, so supplies could be stretched to cover a lot of people. It would trigger no side effect more significant than a sore arm. And it would be easy to ship and store.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EDUCATION: ‘Equity hubs’ give families struggling financially a chance at pandemic pods

Surging virus, plummeting temperatures challenge shelters

PORTLAND, Ore. (AP) — After three years on the streets, Tiecha Vannoy and her boyfriend Chris Foss plan to weather the pandemic this winter in a small white “pod” with electricity, heat and enough room for two.

Problem, Solution, SitRep, or ?: 

Why you still need to wear a mask after getting COVID-19 vaccine

As the promise of a COVID-19 vaccine is fulfilled amid the rollout of the Pfizer/BioNTech and Moderna vaccines, the need to continue wearing masks, washing your hands and maintaining social distancing remains mission critical to protecting lives.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OVERVIEW: U.S. Cases See Christmas Low; Japan’s Entry Ban: Virus Update

What we know about the UK coronavirus variant

Pages

Subscribe to Global RSS
howdy folks
Page loaded in 1.003 seconds.